From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards

BACKGROUND: A comprehensive understanding of cancer has been furthered with technological improvements and decreasing costs of next-generation sequencing (NGS). However, the complexity of interpreting genomic data is hindering the implementation of high-throughput technologies in the clinical contex...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Genome Med
Auteurs principaux: Perera-Bel, Júlia, Hutter, Barbara, Heining, Christoph, Bleckmann, Annalen, Fröhlich, Martina, Fröhling, Stefan, Glimm, Hanno, Brors, Benedikt, Beißbarth, Tim
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5856211/
https://ncbi.nlm.nih.gov/pubmed/29544535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-018-0529-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires